Rheumatoid Arthritis Complicated with Nasal Septum Perforation Due to Methotrexate-associated Lymphoproliferative Disorder

A 44-year-old female with rheumatoid arthritis treated with methotrexate (MTX) and tocilizumab (TCZ) was admitted to our hospital with nasal pain. Nasal fiberscopy revealed septum perforation, while a membrane biopsy indicated granuloma and fibrinoid necrosis of the small artery. The patient was treated with prednisolone 30 mg/day after discontinuation of MTX and TCZ. Inguinal lymph node biopsy revealed diffuse infiltrations of atypical T-cells and Epstein-Barr virus-positive B cells. The patient was diagnosed with peripheral T-cell lymphoma due to MTX-associated lymphoproliferative disorder (MTX-LPD). We herein describe the case of a patient with nasal septum perforation due to MTX-LPD mimicking granulomatosis with polyangiitis.

[1]  道彦 原田,et al.  Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders , 2013, Lymphoma.

[2]  J. Wada,et al.  Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents , 2017, Modern rheumatology.

[3]  T. Takeuchi,et al.  Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate , 2017, Rheumatology.

[4]  I. Auger,et al.  Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study , 2017, PloS one.

[5]  Y. Kaneko.  Methotrexate-associated lymphoproliferative disorder. , 2017, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

[6]  C. Henquell,et al.  Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis. , 2016, Joint, bone, spine : revue du rhumatisme.

[7]  H. Matsuoka,et al.  Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal , 2015, Leukemia & lymphoma.

[8]  R. Haba,et al.  Association of Higher Methotrexate Dose With Lymphoproliferative Disease Onset in Rheumatoid Arthritis Patients , 2014, Arthritis care & research.

[9]  K. Ohshima,et al.  Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein–Barr virus, and clonality are important predictors of disease progression and regression , 2013, European journal of haematology.

[10]  M. Suarez‐Almazor,et al.  Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. , 2012, JAMA.

[11]  M. Kizaki,et al.  Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis , 2012, Leukemia & lymphoma.

[12]  S. Swerdlow,et al.  Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders , 2011 .

[13]  S. Tominaga,et al.  Exacerbation of chronic active Epstein–Barr virus infection in a patient with rheumatoid arthritis receiving humanised anti-interleukin-6 receptor monoclonal antibody , 2006, Annals of the rheumatic diseases.

[14]  H. Jasin,et al.  Vasculitis and lymph op roliferative diseases , 1996 .

[15]  H. Jasin,et al.  Vasculitis and lymphoproliferative diseases. , 1996, Seminars in arthritis and rheumatism.

[16]  B. Wenig,et al.  Non‐Hodgkin's lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases , 1995, Cancer.

[17]  H. Hurwitz,et al.  Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. , 1991, The Journal of rheumatology.

[18]  D. Purtilo,et al.  Cutaneous necrotizing granulomatous vasculitis with evolution to T cell lymphoma. , 1987, The American journal of medicine.